Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium

[Display omitted] Our recent studies have shown that the coadministration of cell-penetrating peptides (CPPs) is a potential strategy for oral delivery of peptide- and protein-based biopharmaceuticals. The intermolecular interaction between drug and CPP is an essential factor in the effective delive...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmaceutics and biopharmaceutics 2015-08, Vol.94, p.42-51
Hauptverfasser: Kamei, Noriyasu, Aoyama, Yukina, Khafagy, El-Sayed, Henmi, Mao, Takeda-Morishita, Mariko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 51
container_issue
container_start_page 42
container_title European journal of pharmaceutics and biopharmaceutics
container_volume 94
creator Kamei, Noriyasu
Aoyama, Yukina
Khafagy, El-Sayed
Henmi, Mao
Takeda-Morishita, Mariko
description [Display omitted] Our recent studies have shown that the coadministration of cell-penetrating peptides (CPPs) is a potential strategy for oral delivery of peptide- and protein-based biopharmaceuticals. The intermolecular interaction between drug and CPP is an essential factor in the effective delivery of these drugs, but the characteristics of the interaction under the conditions of the intestinal lumen remain unknown. In this study, therefore, we examined the characteristics of binding of the amphipathic CPP penetratin to insulin and the efficiency of its enhancement of epithelial insulin transport at different pH and in simulated intestinal fluids (SIFs). The binding between insulin and penetratin was pH dependent and particularly decreased at pH 5.0. In addition, we clarified that the sodium taurocholate (NaTC) present in two types of SIF (fasted-state SIF [FaSSIF] and fed-state SIF [FeSSIF]) affected binding efficiency. However, the permeation of insulin through a Caco-2 cell monolayer was significantly facilitated by coincubation with l- or d-penetratin at various pH values. Moreover, the permeation-stimulating effect of l-penetratin was observed in FaSSIF containing NaTC and lecithin, but not in 3mM NaTC solution, suggesting that the presence of lecithin was the key factor in maintaining the ability of penetratin to enhance the intestinal absorption of biopharmaceuticals. This report describes the essential considerations for in vivo use and clinical application of a CPP-based oral delivery strategy.
doi_str_mv 10.1016/j.ejpb.2015.04.030
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1700104470</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0939641115002106</els_id><sourcerecordid>1700104470</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-7d94bb1e23029b7a0c460abcb4888ef356672eb7922e20722744665d2e4ec83d3</originalsourceid><addsrcrecordid>eNp9Uctu1TAQtRCI3hZ-gAXykk3C2HFeEhtUlYdUiQ2sLduZ9PoqsYPtgPqj_R6cm_JYsbJn5sw5Z3QIecWgZMCat6cST4suObC6BFFCBU_IgXVtVVRCsKfkAH3VF41g7IJcxngCANHW3XNyweu-gaqCA3m4GUc0ifqRDjZ_A7pErUsYk3Vqosa7wSbrXaTe0XTE8zDMfkKzTirspTIbhGpMPxFd7sV1so4qN1CD01Qs6DAFlSnv6IJLsgPSv70zLq_bFDe9FKxez3zJ02xjzjrnMntcsjTuVToGv94d_zWLi80OJ7vOL8izUU0RXz6-V-Tbh5uv15-K2y8fP1-_vy2M4DwV7dALrRnyCnivWwVGNKC00aLrOhyrumlajrrtOUcOLeetEE1TDxwFmq4aqivyZuddgv--Zh9ytnE7WTn0a5SsBWAgRAsZyneoCT7GgKNcgp1VuJcM5JanPMktT7nlKUHInGdeev3Iv-oZhz8rvwPMgHc7APOVPywGGY1FZ3CwIecqB2__x_8LyZ64ww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1700104470</pqid></control><display><type>article</type><title>Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Kamei, Noriyasu ; Aoyama, Yukina ; Khafagy, El-Sayed ; Henmi, Mao ; Takeda-Morishita, Mariko</creator><creatorcontrib>Kamei, Noriyasu ; Aoyama, Yukina ; Khafagy, El-Sayed ; Henmi, Mao ; Takeda-Morishita, Mariko</creatorcontrib><description>[Display omitted] Our recent studies have shown that the coadministration of cell-penetrating peptides (CPPs) is a potential strategy for oral delivery of peptide- and protein-based biopharmaceuticals. The intermolecular interaction between drug and CPP is an essential factor in the effective delivery of these drugs, but the characteristics of the interaction under the conditions of the intestinal lumen remain unknown. In this study, therefore, we examined the characteristics of binding of the amphipathic CPP penetratin to insulin and the efficiency of its enhancement of epithelial insulin transport at different pH and in simulated intestinal fluids (SIFs). The binding between insulin and penetratin was pH dependent and particularly decreased at pH 5.0. In addition, we clarified that the sodium taurocholate (NaTC) present in two types of SIF (fasted-state SIF [FaSSIF] and fed-state SIF [FeSSIF]) affected binding efficiency. However, the permeation of insulin through a Caco-2 cell monolayer was significantly facilitated by coincubation with l- or d-penetratin at various pH values. Moreover, the permeation-stimulating effect of l-penetratin was observed in FaSSIF containing NaTC and lecithin, but not in 3mM NaTC solution, suggesting that the presence of lecithin was the key factor in maintaining the ability of penetratin to enhance the intestinal absorption of biopharmaceuticals. This report describes the essential considerations for in vivo use and clinical application of a CPP-based oral delivery strategy.</description><identifier>ISSN: 0939-6411</identifier><identifier>EISSN: 1873-3441</identifier><identifier>DOI: 10.1016/j.ejpb.2015.04.030</identifier><identifier>PMID: 25960330</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Administration, Oral ; Caco-2 Cells ; Carrier Proteins - chemistry ; Carrier Proteins - metabolism ; Cell-penetrating peptide ; Chemistry, Pharmaceutical ; Drug Carriers ; Epithelial Cells - metabolism ; Humans ; Hydrogen-Ion Concentration ; Hypoglycemic Agents - administration &amp; dosage ; Hypoglycemic Agents - chemistry ; Hypoglycemic Agents - metabolism ; Insulin ; Insulin - administration &amp; dosage ; Insulin - chemistry ; Insulin - metabolism ; Intermolecular interaction ; Intestinal Absorption ; Intestinal Mucosa - metabolism ; Kinetics ; Lecithins - chemistry ; Models, Biological ; Oral absorption ; Penetratin ; Permeability ; Protein Binding ; Taurocholic Acid - chemistry ; Technology, Pharmaceutical - methods ; Tight Junctions - metabolism</subject><ispartof>European journal of pharmaceutics and biopharmaceutics, 2015-08, Vol.94, p.42-51</ispartof><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-7d94bb1e23029b7a0c460abcb4888ef356672eb7922e20722744665d2e4ec83d3</citedby><cites>FETCH-LOGICAL-c422t-7d94bb1e23029b7a0c460abcb4888ef356672eb7922e20722744665d2e4ec83d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejpb.2015.04.030$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25960330$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kamei, Noriyasu</creatorcontrib><creatorcontrib>Aoyama, Yukina</creatorcontrib><creatorcontrib>Khafagy, El-Sayed</creatorcontrib><creatorcontrib>Henmi, Mao</creatorcontrib><creatorcontrib>Takeda-Morishita, Mariko</creatorcontrib><title>Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium</title><title>European journal of pharmaceutics and biopharmaceutics</title><addtitle>Eur J Pharm Biopharm</addtitle><description>[Display omitted] Our recent studies have shown that the coadministration of cell-penetrating peptides (CPPs) is a potential strategy for oral delivery of peptide- and protein-based biopharmaceuticals. The intermolecular interaction between drug and CPP is an essential factor in the effective delivery of these drugs, but the characteristics of the interaction under the conditions of the intestinal lumen remain unknown. In this study, therefore, we examined the characteristics of binding of the amphipathic CPP penetratin to insulin and the efficiency of its enhancement of epithelial insulin transport at different pH and in simulated intestinal fluids (SIFs). The binding between insulin and penetratin was pH dependent and particularly decreased at pH 5.0. In addition, we clarified that the sodium taurocholate (NaTC) present in two types of SIF (fasted-state SIF [FaSSIF] and fed-state SIF [FeSSIF]) affected binding efficiency. However, the permeation of insulin through a Caco-2 cell monolayer was significantly facilitated by coincubation with l- or d-penetratin at various pH values. Moreover, the permeation-stimulating effect of l-penetratin was observed in FaSSIF containing NaTC and lecithin, but not in 3mM NaTC solution, suggesting that the presence of lecithin was the key factor in maintaining the ability of penetratin to enhance the intestinal absorption of biopharmaceuticals. This report describes the essential considerations for in vivo use and clinical application of a CPP-based oral delivery strategy.</description><subject>Administration, Oral</subject><subject>Caco-2 Cells</subject><subject>Carrier Proteins - chemistry</subject><subject>Carrier Proteins - metabolism</subject><subject>Cell-penetrating peptide</subject><subject>Chemistry, Pharmaceutical</subject><subject>Drug Carriers</subject><subject>Epithelial Cells - metabolism</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Hypoglycemic Agents - administration &amp; dosage</subject><subject>Hypoglycemic Agents - chemistry</subject><subject>Hypoglycemic Agents - metabolism</subject><subject>Insulin</subject><subject>Insulin - administration &amp; dosage</subject><subject>Insulin - chemistry</subject><subject>Insulin - metabolism</subject><subject>Intermolecular interaction</subject><subject>Intestinal Absorption</subject><subject>Intestinal Mucosa - metabolism</subject><subject>Kinetics</subject><subject>Lecithins - chemistry</subject><subject>Models, Biological</subject><subject>Oral absorption</subject><subject>Penetratin</subject><subject>Permeability</subject><subject>Protein Binding</subject><subject>Taurocholic Acid - chemistry</subject><subject>Technology, Pharmaceutical - methods</subject><subject>Tight Junctions - metabolism</subject><issn>0939-6411</issn><issn>1873-3441</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Uctu1TAQtRCI3hZ-gAXykk3C2HFeEhtUlYdUiQ2sLduZ9PoqsYPtgPqj_R6cm_JYsbJn5sw5Z3QIecWgZMCat6cST4suObC6BFFCBU_IgXVtVVRCsKfkAH3VF41g7IJcxngCANHW3XNyweu-gaqCA3m4GUc0ifqRDjZ_A7pErUsYk3Vqosa7wSbrXaTe0XTE8zDMfkKzTirspTIbhGpMPxFd7sV1so4qN1CD01Qs6DAFlSnv6IJLsgPSv70zLq_bFDe9FKxez3zJ02xjzjrnMntcsjTuVToGv94d_zWLi80OJ7vOL8izUU0RXz6-V-Tbh5uv15-K2y8fP1-_vy2M4DwV7dALrRnyCnivWwVGNKC00aLrOhyrumlajrrtOUcOLeetEE1TDxwFmq4aqivyZuddgv--Zh9ytnE7WTn0a5SsBWAgRAsZyneoCT7GgKNcgp1VuJcM5JanPMktT7nlKUHInGdeev3Iv-oZhz8rvwPMgHc7APOVPywGGY1FZ3CwIecqB2__x_8LyZ64ww</recordid><startdate>20150801</startdate><enddate>20150801</enddate><creator>Kamei, Noriyasu</creator><creator>Aoyama, Yukina</creator><creator>Khafagy, El-Sayed</creator><creator>Henmi, Mao</creator><creator>Takeda-Morishita, Mariko</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150801</creationdate><title>Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium</title><author>Kamei, Noriyasu ; Aoyama, Yukina ; Khafagy, El-Sayed ; Henmi, Mao ; Takeda-Morishita, Mariko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-7d94bb1e23029b7a0c460abcb4888ef356672eb7922e20722744665d2e4ec83d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Administration, Oral</topic><topic>Caco-2 Cells</topic><topic>Carrier Proteins - chemistry</topic><topic>Carrier Proteins - metabolism</topic><topic>Cell-penetrating peptide</topic><topic>Chemistry, Pharmaceutical</topic><topic>Drug Carriers</topic><topic>Epithelial Cells - metabolism</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Hypoglycemic Agents - administration &amp; dosage</topic><topic>Hypoglycemic Agents - chemistry</topic><topic>Hypoglycemic Agents - metabolism</topic><topic>Insulin</topic><topic>Insulin - administration &amp; dosage</topic><topic>Insulin - chemistry</topic><topic>Insulin - metabolism</topic><topic>Intermolecular interaction</topic><topic>Intestinal Absorption</topic><topic>Intestinal Mucosa - metabolism</topic><topic>Kinetics</topic><topic>Lecithins - chemistry</topic><topic>Models, Biological</topic><topic>Oral absorption</topic><topic>Penetratin</topic><topic>Permeability</topic><topic>Protein Binding</topic><topic>Taurocholic Acid - chemistry</topic><topic>Technology, Pharmaceutical - methods</topic><topic>Tight Junctions - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kamei, Noriyasu</creatorcontrib><creatorcontrib>Aoyama, Yukina</creatorcontrib><creatorcontrib>Khafagy, El-Sayed</creatorcontrib><creatorcontrib>Henmi, Mao</creatorcontrib><creatorcontrib>Takeda-Morishita, Mariko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kamei, Noriyasu</au><au>Aoyama, Yukina</au><au>Khafagy, El-Sayed</au><au>Henmi, Mao</au><au>Takeda-Morishita, Mariko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium</atitle><jtitle>European journal of pharmaceutics and biopharmaceutics</jtitle><addtitle>Eur J Pharm Biopharm</addtitle><date>2015-08-01</date><risdate>2015</risdate><volume>94</volume><spage>42</spage><epage>51</epage><pages>42-51</pages><issn>0939-6411</issn><eissn>1873-3441</eissn><abstract>[Display omitted] Our recent studies have shown that the coadministration of cell-penetrating peptides (CPPs) is a potential strategy for oral delivery of peptide- and protein-based biopharmaceuticals. The intermolecular interaction between drug and CPP is an essential factor in the effective delivery of these drugs, but the characteristics of the interaction under the conditions of the intestinal lumen remain unknown. In this study, therefore, we examined the characteristics of binding of the amphipathic CPP penetratin to insulin and the efficiency of its enhancement of epithelial insulin transport at different pH and in simulated intestinal fluids (SIFs). The binding between insulin and penetratin was pH dependent and particularly decreased at pH 5.0. In addition, we clarified that the sodium taurocholate (NaTC) present in two types of SIF (fasted-state SIF [FaSSIF] and fed-state SIF [FeSSIF]) affected binding efficiency. However, the permeation of insulin through a Caco-2 cell monolayer was significantly facilitated by coincubation with l- or d-penetratin at various pH values. Moreover, the permeation-stimulating effect of l-penetratin was observed in FaSSIF containing NaTC and lecithin, but not in 3mM NaTC solution, suggesting that the presence of lecithin was the key factor in maintaining the ability of penetratin to enhance the intestinal absorption of biopharmaceuticals. This report describes the essential considerations for in vivo use and clinical application of a CPP-based oral delivery strategy.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>25960330</pmid><doi>10.1016/j.ejpb.2015.04.030</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0939-6411
ispartof European journal of pharmaceutics and biopharmaceutics, 2015-08, Vol.94, p.42-51
issn 0939-6411
1873-3441
language eng
recordid cdi_proquest_miscellaneous_1700104470
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Administration, Oral
Caco-2 Cells
Carrier Proteins - chemistry
Carrier Proteins - metabolism
Cell-penetrating peptide
Chemistry, Pharmaceutical
Drug Carriers
Epithelial Cells - metabolism
Humans
Hydrogen-Ion Concentration
Hypoglycemic Agents - administration & dosage
Hypoglycemic Agents - chemistry
Hypoglycemic Agents - metabolism
Insulin
Insulin - administration & dosage
Insulin - chemistry
Insulin - metabolism
Intermolecular interaction
Intestinal Absorption
Intestinal Mucosa - metabolism
Kinetics
Lecithins - chemistry
Models, Biological
Oral absorption
Penetratin
Permeability
Protein Binding
Taurocholic Acid - chemistry
Technology, Pharmaceutical - methods
Tight Junctions - metabolism
title Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T02%3A57%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20different%20intestinal%20conditions%20on%20the%20intermolecular%20interaction%20between%20insulin%20and%20cell-penetrating%20peptide%20penetratin%20and%20on%20its%20contribution%20to%20stimulation%20of%20permeation%20through%20intestinal%20epithelium&rft.jtitle=European%20journal%20of%20pharmaceutics%20and%20biopharmaceutics&rft.au=Kamei,%20Noriyasu&rft.date=2015-08-01&rft.volume=94&rft.spage=42&rft.epage=51&rft.pages=42-51&rft.issn=0939-6411&rft.eissn=1873-3441&rft_id=info:doi/10.1016/j.ejpb.2015.04.030&rft_dat=%3Cproquest_cross%3E1700104470%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1700104470&rft_id=info:pmid/25960330&rft_els_id=S0939641115002106&rfr_iscdi=true